Ublituximab Efficacy Outcomes in Relapsing Multiple Sclerosis Patient Subgroups in the ULTIMATE I and II Studies

Drug Category: Array
Conference Category: Array
Lead Author: Hartung P, et al.
Published Date: 26/06/2022
Download Link: /wp-content/uploads/2022/06/Hartung-1054-TG-EAN-2022-Subpopulations-poster-15Jun22b.pdf
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top